对湿疹的局部抗炎疗法:网络元分析
Stephanie J Lax1, Eleanor Van Vogt2, Bridget Candy1
1Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
The Cochrane database of systematic reviews
|August 6, 2024
概括
这一网络元分析发现,强效局部皮质类固醇 (TCS) 和0.1%的塔克罗利对于湿疹具有高度的效果. 虽然TCS没有显示短期皮肤变薄,但长期使用与这种副作用有关.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 证据综合 证据综合
背景情况:
- 湿疹 (皮炎) 是一种全球普遍存在的皮肤疾病,缺乏预防或治疗治疗方法.
- 局部抗炎治疗是症状控制的标准,但它们的比较有效性和安全性仍然不清楚.
研究的目的:
- 进行网络元分析,比较和排名各种局部抗炎治疗湿疹的疗效和安全性.
主要方法:
- 系统地搜索多个数据库和试验注册表,直到2023年6月.
- 包括随机对照试验 (RCT),比较任何年龄组的湿疹局部抗炎药物治疗.
- 网络元分析 (NMA) 来评估主要结果:患者报告的症状,临床医生报告的症状和调查人员的全球评估 (IGA). 二次结果包括生活质量和不良影响.
主要成果:
- 强效局部皮质类固醇 (TCS),类激酶 (JAK) 抑制剂和0.1%的塔克罗利总是被列为治疗湿疹最有效的治疗方法之一.
- 固酶-4 (PDE-4) 抑制剂,轻度TCS和1%的塔皮纳一般被列为在多个疗效结局中最不有效的药物.
- 局部氨酸抑制剂 (TCI) 和2%的克里萨博罗尔与局部应用部位反应的可能性更高有关,而TCS的可能性较小. 短期使用TCS没有显示皮肤变薄的风险增加,但长期使用与这种不良影响有关.
结论:
- 强大的TCS,JAK抑制剂和0.1%的塔克罗利斯在治疗湿疹方面表现出卓越的疗效.
- 与其他治疗相比,PDE-4抑制剂和轻度的TCS似乎效果较差.
- 虽然短期使用TCS对于皮肤变薄是安全的,但长时间使用可能会导致这种副作用. TCI和crisaborol携带更高的局部反应风险.
相关概念视频
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
232
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
232
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
261
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
261